文献速递肺外科

非小细胞肺癌肺叶切除术中淋巴结采样与临床量的关联

Association of Lymph Node Sampling and Clinical Volume in Lobectomy for Non-Small Cell Lung Cancer.
PubMed 文献 · Ann Thorac Surg · 2022-06-22

基于胸外科医师学会普胸数据库2012-2019年305个中心43597例择期肺叶切除术,按年手术量三分位分组,发现中、高容量中心平均每例切除≥10枚淋巴结的比率显著高于低容量中心,但25%高容量中心平均仍不足10枚。

要点

  • 低、中、高容量中心年均肺叶切除量中位数分别为6.2、19.9、42.7例。
  • 平均每例切除≥10枚淋巴结的比率:低容量44.0%、中容量70.6%、高容量75.2%(P<.001)。
  • 多变量分析中,中容量中心OR 2.94(95%CI 1.57-5.50,P<.01),高容量中心OR 3.82(95%CI 1.95-7.46,P<.001)。

核心结论

  • 中心手术量与淋巴结获取量相关,但25%的高容量中心平均每例肺叶切除术获取淋巴结少于10枚。
  • 淋巴结获取不足可能低估分期,影响辅助治疗和长期生存。

研究设计与样本

  • 基于胸外科医师学会普胸外科数据库2012-2019年数据,纳入305个中心43597例择期非小细胞肺癌肺叶切除术患者。
  • 参与中心按年手术量三分位分组,比较平均每例肺叶切除术获取≥10枚淋巴结的比率。

主要发现

  • 低、中、高容量中心年均肺叶切除量中位数分别为6.2、19.9、42.7例。
  • 43597例肺叶切除术中,低容量中心占5.6%,中容量中心占24.0%,高容量中心占70.4%。
  • 平均每例切除≥10枚淋巴结的比率:低容量中心44.0%,中容量中心70.6%,高容量中心75.2%(P<.001)。
  • 多变量分析显示,中容量中心(OR 2.94;95%CI 1.57-5.50;P<.01)和高容量中心(OR 3.82;95%CI 1.95-7.46;P<.001)与平均每例切除≥10枚淋巴结独立相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sampling of ≥10 lymph nodes during lobectomy for non-small cell lung cancer (NSCLC) was a previous surveillance metric and potential quality metric of the American College of Surgeons Commission on Cancer. We sought to determine guideline adherence and its relationship to hospital lobectomy volume within The Society of Thoracic Surgeons General Thoracic Surgery Database. METHODS: Participant centers providing elective lobectomy for NSCLC within The Society of Thoracic Surgeons General Thoracic Surgery Database (2012-2019) were divided into tertiles according to annual volume. Average hospital nodal harvest of ≥10 nodes per lobectomy defined the primary outcome. Univariable analysis compared average patient and operative characteristics between the participant centers. Multivariable logistic regression was used to determine independent factors associated with average clinical center nodal harvest of ≥10 nodes. RESULTS: Median annual lobectomy volume was 6.2, 19.9, and 42.7 for low-, medium-, and high-volume participant centers. Among 305 centers and 43 597 patients, 5.6% of lobectomies occurred in low-volume centers, 24.0% in medium-volume centers, and 70.4% in high-volume centers. Average rates of ≥10 nodes per lobectomy were excised in 44.0% of low-volume centers, 70.6% of medium-volume centers, and 75.2% of high-volume centers (P < .001). On multivariable analysis, average nodal excision of ≥10 nodes was strongly associated with medium-volume (odds ratio, 2.94; CI, 1.57-5.50, P < .01) and high-volume (odds ratio, 3.82; CI, 1.95-7.46; P < .001) participant centers. CONCLUSIONS: Although higher center volume and increased nodal harvest are associated, 25% of high-volume centers average a rate of <10 lymph nodes per lobectomy for NSCLC. Low nodal yield may underestimate stage, with implications for adjuvant therapy and long-term survival.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Udelsman BV, Chang DC, Boffa DJ, et al. Association of Lymph Node Sampling and Clinical Volume in Lobectomy for Non-Small Cell Lung Cancer. Ann Thorac Surg. 2022. PMID: 35752354. doi:10.1016/j.athoracsur.2022.05.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。